All the Active Ingredient Drugs
Corticosteroid, Selective β2 Agonist. Budesonide 160 mcg, 320 mcg, Formoterol Fumarate 4.5 mcg, 9 mcg. MULTI-DOSE INHALER (pwdr. for inhal): 120 doses ×160 mcg/4.5 mcg, 60 doses × 320 mcg/9 mcg.
160 mcg/4.5 mcg as monother., prevent. recur. of asthma sympt. Adult.: 1,2 inhal. ×2/dmay be decreas. to once dly., or incr. to 4 inhal.×2/d. As comb. tmt. with a “supplement. inhaler”adults): 1 inhal. in the morn. and one inhal. in the eve. Or 2 inhal. in the morn. Or 2 inhal. in the eve. May be incr. to 2 inhal. twice dly. 320 mcg/ 9 mcg As monother. adult.: 1 inhal.×2/d. may be incr. to 2 inhal. ×2/d, or decreas. to once dly.
Indic. in adlts. 18 yrs. of age and older only. Regular tmt. of asthma, where use of a comb.n (inhaled corticosteroid and long-act. β2 adrenoceptor agonist) is appropriate: In pts. not adequately control. with inhaled corticosteroids and “as needed” inhaled shortacting β2 adrenoceptor ag. Or in pts. already adequately controlled on both inhaled corticosteroids and long-act. β2 adrenoceptor ag.
C/I: Hypersens. Hypersens. to lactose.
Corticosteroid, Selective β2 Agonist. Fluticasone Propionate 50, 125, 250 mcg, Formoterol Fumarate 5 mcg, 10 mcg. Press. inhal., susp. + canister, INHALER:
Twice dly. Pts. with poorly control.
asthma the total daily dose can be incr.
by administ. a higher strength of this
Tmt. Of asthma in pts. Are not adequate.
Control. With inhal. Corticosteroids and ‘as
required’ inhal. Short –act. Β2 agon.
Or For patients already adequate.control.
on both an inhal. corticosteroid and a
C/I: Hypersens. to the active subst. or to
any of it's excip.
Selective β2 Agonist. Formoterol Fumarate 12 mcg. INHAL. CAPS: (dry pwdr): 30, 60 x 12 μg/
cap. 1 inhal. cap. 2 x dly or more if reqd.
Max: 4 dly.
Revers. airways obstruct. incl. nocturnal
asth., exc. induced bronchosp., in pts. req.
long-term reg. bronchodilat. ther. Proph.
and tmt. bronchoconstrict. in pts. with
COPD, incl. bronchit. and emphysema.
Corticosteroid, β2 Agonist. Beclometasone Dipropionate Anhydrous 100 mcg/metered dose, Formoterol Fumarate (dihydrate) 6 mcg/metered dose. SOL. FOR INHAL.(with inhal. device): 120 actuat. Asthma: Maint. therapy for pts. 18 yrs. and above- 1, 2 inhal. ×2/d. max. dly. dose is 4 inhal. Maint. & reliever ther.: Pts. 18 yrs. and above- 1 inhal. ×2/d. max. dly. dose is 8 inhal.COPD: For pts. 18 yrs. and above- 2 inhal. ×2/d. See lit.
Asthma: Regular tmt. of asthma where use of a combin. product (inhaled corticost.&long-acting β2-agonist) is approp. Pts. not adequate. control. with inhal. corticoster. and ‘as needed’ inhal. rapid-act. beta2-agonist. Pts. already adequat. control. on both inhal. corticoster. and long-act. β2-agonist. COPD :Symptom. tmt. of pts. with severe COPD (FEV1 < 50% predicted normal) and a hist. of repeated exacerb., who have signific. sympt. despite regular ther. with long-act. bronchodilators.
Corticosteroid, Selective β2 Agonist. Budesonide 160 mcg/dose, Formoterol Fumarate 4.5 mcg/dose. TURBUHALER: 60, 120 doses x 160/4.5 μg/inhal. 160/4.5 μg/inhal: Asth: Adults over 18 yrs: 1-2 inhal. 2 x dly. Some pts. may req. up to max of 4 inhal. 2 x dly.
Adolesc. (12-17 yrs): 1-2 inhal. 2 x dly.
For child: The lower strength of 80/4.5
μg/inhal. is avail. COPD: Adults: 2 inhal.
2 x dly. Elderly: No need for adjust.
Reg. tmt. bronch. asth. where comb. tmt of
corticosteroid and long-act. beta agonist
is approp. Pts. not adequat. controlled
with inhal. corticoster. and “as needed”
inhal. short act. β2 - agonists, or pts.
adequat. controlled on both inhal.
corticoster. and long-act. β2 - agonists.
Sympt. tmt. severe COPD (FEVI <50%
predicted normal), history repeated
exacerbats. despite reg. ther. with longact.
C/I: Known hypersens. to compon.